Updates on Use of Genomic Testing in Patients with High-Risk, Clinically Localized Prostate Cancer - Episode 5

Addressing Clinical Challenges of Prostate Cancer Management with the Use of Genomic Testing

August 2, 2022

Stephen J. Freedland, MD, details which patient populations he orders genomic testing for, and how the tests can address clinical challenges in prostate cancer treatment.

EP. 1: Staging, Grading, and Risk Stratification of Prostate Cancer

EP. 2: Treatment Options for High-Risk, Clinically Localized Prostate Cancer

EP. 3: Clinical Challenges Surrounding Treatment Decision-Making in Clinically Localized Prostate Cancer

EP. 4: The Potential for Overtreatment or Undertreatment of Prostate Cancer

Now Viewing

EP. 5: Addressing Clinical Challenges of Prostate Cancer Management with the Use of Genomic Testing

EP. 6: Available Genomic Tests for Clinically Localized Prostate Cancer

EP. 7: Clinical Study Data in Prostate Cancer Genomic Testing

EP. 8: Clinical Implications of Using Genomic Testing Results in Prostate Cancer Risk-Stratification and Treatment Selection

EP. 9: Exciting Emerging Data in Prostate Cancer